As of May 26
| -0.07 / -0.06%|
The 21 analysts offering 12-month price forecasts for Zimmer Biomet Holdings Inc have a median target of 134.00, with a high estimate of 155.00 and a low estimate of 92.00. The median estimate represents a +12.39% increase from the last price of 119.23.
The current consensus among 27 polled investment analysts is to Buy stock in Zimmer Biomet Holdings Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.